Germline p.T790M and p.V843I in epidermal growth factor receptor (EGFR) and parkin RBR E3 ubiquitin protein ligase (PARK2) loss-of-function mutations have been identified in these families and suggested to confer the high susceptibility to lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.